HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nail Polish Ingredient No Good For Kids’ Products, EC Committee Says

This article was originally published in The Rose Sheet

Executive Summary

The European Commission's Scientific Committee on Consumer Products (SCCP) is advising against the use of nail polish ingredient toluene in products targeted to children

You may also be interested in...



Opinions Requested From European Scientific Committee On UV Filter, Toluene

The European Commission is requesting opinions from its Scientific Committee on Consumer Products (SCCP) on the UV filter benzophenone-3 (2-hydroxy-4-methoxybenzophenone) and toluene, used as a solvent in nail products

EC Asks For Scientific Committee’s Stance On Five Cosmetic Ingredients

The European Commission is soliciting opinions from its Scientific Committee on Consumer Products on five cosmetic ingredients - one fragrance and four hair-dye ingredients - in requests dated April 27

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel